COLLECTION SPONSOR
We are grateful for the support of our sponsor Sirtris Pharmaceuticals, Inc. As always, Nature carries sole responsibility for all editorial content.
Top of pageProduced with support from: Sirtris Pharmaceuticals, Inc.
Sirtris Pharmaceuticals (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small-molecule drugs with the potential to treat diseases associated with aging. Our drug candidates are designed to mimic certain beneficial health effects of calorie restriction, without requiring a change in eating habits. They do this by activating SIRT1, a member of a recently discovered class of enzymes called sirtuins. Our most advanced programs are focused on developing activators of SIRT1 and include SRT501, our proprietary formulation of resveratrol, a natural substance found in red wine and other plant products. We are confident that drug development targeting sirtuins has the potential to address a broad range of diseases of aging, such as metabolic and mitochondrial disorders like type 2 diabetes, as well as cancer and neurological disorders. For more information, please visit the Sitris Pharmaceuticals website.
